Dr Reddys Stock Performance

RDY
 Stock
  

USD 54.66  0.10  0.18%   

Dr Reddys has a performance score of 4 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.6055, which means possible diversification benefits within a given portfolio. Let's try to break down what Dr Reddys's beta means in this case. As returns on the market increase, Dr Reddys returns are expected to increase less than the market. However, during the bear market, the loss on holding Dr Reddys will be expected to be smaller as well. Although it is important to respect Dr Reddys Laboratories existing price patterns, it is better to be realistic regarding the information on the equity's price patterns. The way of predicting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By reviewing Dr Reddys Laboratories technical indicators, you can right now evaluate if the expected return of 0.0797% will be sustainable into the future. Dr Reddys Laboratories at this time owns a risk of 1.5%. Please confirm Dr Reddys Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Dr Reddys Laboratories will be following its current price history.
  
Dr Reddys Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more

Structure and Payout Changes

Forward Annual Dividend Yield
0.0061
Payout Ratio
0.33
Last Split Factor
2:1
Forward Annual Dividend Rate
0.34
Dividend Date
2022-08-12
Ex Dividend Date
2021-07-08

Dr Reddys Price Channel

Quick Ratio1.23
Fifty Two Week Low47.88
Target High Price66.00
Payout Ratio13.98%
Fifty Two Week High65.86
Target Low Price57.00
Trailing Annual Dividend Yield45.89%

Dr Reddys Relative Risk vs. Return Landscape

If you would invest  5,229  in Dr Reddys Laboratories on August 31, 2022 and sell it today you would earn a total of  227.00  from holding Dr Reddys Laboratories or generate 4.34% return on investment over 90 days. Dr Reddys Laboratories is generating 0.0797% of daily returns assuming volatility of 1.5001% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than Dr Reddys, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Dr Reddys is expected to generate 1.57 times less return on investment than the market. In addition to that, the company is 1.07 times more volatile than its market benchmark. It trades about 0.05 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.09 per unit of volatility.

Dr Reddys Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Reddys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dr Reddys Laboratories, and traders can use it to determine the average amount a Dr Reddys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0531

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
RDYHigh
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 1.5
  actual daily
 
 13 %
of total potential
 
1313
Expected Return
 0.08
  actual daily
 
 1 %
of total potential
 
11
Risk-Adjusted Return
 0.05
  actual daily
 
 4 %
of total potential
 
44
Based on monthly moving average Dr Reddys is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Reddys by adding it to a well-diversified portfolio.

About Dr Reddys Performance

To evaluate Dr Reddys Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Dr Reddys generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Dr Reddys Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Dr Reddys Laboratories market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Dr Reddys's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 24795 people.

Things to note about Dr Reddys Laboratories

Checking the ongoing alerts about Dr Reddys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dr Reddys Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Dr Reddys Alerts

Equity Alerts and Improvement Suggestions

Dr Reddys has high likelihood to experience some financial distress in the next 2 years
Latest headline from news.google.com: Dr. Reddys Laboratories To Face Antitrust Litigation, Along With Other Generic Pharma Companies In US, - Inventiva
Additionally, take a look at Your Equity Center. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know Dr Reddys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.12
Market Capitalization
B
Quarterly Revenue Growth YOY
0.094
Return On Assets
0.0903
Return On Equity
0.16
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of Dr Reddys that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine Dr Reddys value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.